T. Berl
Endocrinology, Diabetes and Metabolism · 2001–2009
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Endocrinology, Diabetes and Metabolism — 7 citations into it
- Clinical Biochemistry — 5 citations into it
Whom T. Berl trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts T. Berl overall
Papers from T. Berl's perspective
Ordered by how strongly the researchers T. Berl trusts endorse each paper. Same corpus, a different order for every researcher.
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (Journal of the American Medical Association (JAMA))
- Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. (American Journal of Physiology. Endocrinology and Metabolism)
- Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. (Journal of the American College of Cardiology)
- The Cardiorenal Syndrome (International Journal of Nephrology)
- High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. (Journal of Cardiac Failure)
- Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure (Journal of the American College of Cardiology)
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
- Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. (Journal of the American College of Cardiology)
- Cardiorenal interactions: insights from the ESCAPE trial. (Journal of the American College of Cardiology)
- Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. (Circulation Research)
Their papers
- Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative (2009) — 1,044 citations
- Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. (2006) — 1,194 citations
- Pathogenesis of Diabetic Nephropathy (2004) — 631 citations
- Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. (2001) — 5,870 citations